Cancer Institute A national cancer institute
designated cancer center

Find a Physician

Email this profile
Portrait View Larger

Wen-Kai Weng, MD, PhD

Academic Appointments

  • Assistant Professor of Medicine (Blood and Marrow Transplantation) and, by courtesy, of Dermatology at the Stanford University Medical Center

Key Documents

Contact Information

  • Clinical Offices
    Blood and Marrow Transplant Clinic 875 Blake Wilbur Dr Clinic F MC 5826 Stanford, CA 94305
    Tel Work (650) 498-6000 Fax (650) 498-6919
  • Academic Offices
    Personal Information
    Email Tel (650) 723-7689
    Alternate Contact
    Janice Smith Administrative Associate Tel Work 650-724-4155
    Not for medical emergencies or patient use

Professional Overview

Clinical Focus

  • Blood and Marrow Transplant
  • Lymphoma
  • Cutaneous T-Cell Lymphoma
  • Medical Oncology
  • Myeloma

Administrative Appointments

  • Scientific Advisory Board, Lymphoma Research Foundation (2011 - present)

Honors and Awards

  • Translational Research Grant, Stanford Cancer Institute (2014-2015)
  • Division Teaching Award, BMT, Stanford University (2012)
  • Developmental Research Award, Stanford Cancer Institute (2012-2013)
  • ITI Seed Grant Award, Institute for Immunity, Transplantation and Infection, Stanford University (2011-2012)
  • Division Teaching Award, BMT, Stanford University (2010)
  • Developmental Research Award, Stanford University Cancer Center (2009-2010)
View All 12honors and awards of Wen-Kai Weng

Professional Education

Medical Education: Chungshan Medical College (1988)
University of Minnesota MN (1996)
Internship: University of Texas Medical School TX (1997)
Residency: University of Texas Medical School TX (1999)
Fellowship: Stanford University School of Medicine CA (2002)
Board Certification: Internal Medicine, American Board of Internal Medicine (2007)
View All 7



Graduate and Fellowship Program Affiliations

Scientific Focus

Current Research and Scholarly Interests

My clinical focus is non-Hodgkin's lymphoma (NHL) and am currently conducting clinical trials with novel therapies on these patients. My basic research interest is immunotherapy for lymphoma, with two components: tumor vaccines and allogeneic transplant. For the tumor vaccine, I am working with my colleagues in Oncology to conduct a clinical trial using a CpG-activated tumor vaccine in mantel cell NHL patients who undergo autologous transplantation. The goal is to sensitize the autologous T cells to recognize the malignant lymphoma cells and to expand these tumor-specific T cells immediate after autologous transplant.

Second, I am conducting a study using a novel non-myeloablative preparative regimen prior to allogeneic transplant in patients with mycosis fungoides/Sezary syndrome, a cutaneous T cell NHL. While these patients exhibit little sensitivity to traditional chemotherapy, graft-versus-lymphoma effect provided by allogeneic transplant seems to have an excellent disease control effect. I also use high throughput sequencing technology to assess the minimal residual disease and the immune reconstitution after allogeneic transplant.


Publication tag cloud

Publication Topics

View All 27

Stanford Medicine Resources:

Footer Links: